Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors
Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in...
Gespeichert in:
Veröffentlicht in: | Pharmacological research 2016-01, Vol.103, p.292-299 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 299 |
---|---|
container_issue | |
container_start_page | 292 |
container_title | Pharmacological research |
container_volume | 103 |
creator | Sheffield, Kristen S A Vohra, Rahul Scott, John A Ross, Gregory M |
description | Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy. |
doi_str_mv | 10.1016/j.phrs.2015.12.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762347561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1762347561</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-c5c8130afece72e7cb05330adb54f8ce18caa866c968f5e7ba99c0fd1226cebe3</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdBbK3-AQ-yx3pI3Em6m-QoxVahVJD2HDabid2S7Mbd5FD_if_WBT_A0zAvz_swDCE3wGJgIO6PcX9wPk4Y8BiSmDF-RqbAChEB5GJCLr0_MsaKBbALMkmEyHgGYko-916bN-pH10iFtG-l76yhDr010oTE96gGZ72y_YkOlqqDdFIN6PQH0uGAVJuDrvSgQ8s2dLteRX3G59vd6x2Vpqa9s_8ybUI3CALvaXWivpNtSzvbohrbP5t1_oqcN7L1eP0zZ2S_etwtn6LNy_p5-bCJ-gRgiBRXOaRMNqgwSzBTFeNp2OuKL5pcIeRKylwIVYi84ZhVsigUa2pIEqGwwnRG5t_ecOn7iH4oO-0Vtq00aEdfQiaSdJFxAQG9_UHHqsO67J3upDuVv-9MvwDc8XlK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1762347561</pqid></control><display><type>article</type><title>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sheffield, Kristen S A ; Vohra, Rahul ; Scott, John A ; Ross, Gregory M</creator><creatorcontrib>Sheffield, Kristen S A ; Vohra, Rahul ; Scott, John A ; Ross, Gregory M</creatorcontrib><description>Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.</description><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2015.12.005</identifier><identifier>PMID: 26675716</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Heterocyclic Compounds, 3-Ring - pharmacology ; Nerve Growth Factor - antagonists & inhibitors ; Nerve Growth Factor - metabolism ; Pteridines - pharmacology ; Quinazolines - pharmacology ; Receptor, Nerve Growth Factor - metabolism ; Surface Plasmon Resonance</subject><ispartof>Pharmacological research, 2016-01, Vol.103, p.292-299</ispartof><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26675716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheffield, Kristen S A</creatorcontrib><creatorcontrib>Vohra, Rahul</creatorcontrib><creatorcontrib>Scott, John A</creatorcontrib><creatorcontrib>Ross, Gregory M</creatorcontrib><title>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.</description><subject>Heterocyclic Compounds, 3-Ring - pharmacology</subject><subject>Nerve Growth Factor - antagonists & inhibitors</subject><subject>Nerve Growth Factor - metabolism</subject><subject>Pteridines - pharmacology</subject><subject>Quinazolines - pharmacology</subject><subject>Receptor, Nerve Growth Factor - metabolism</subject><subject>Surface Plasmon Resonance</subject><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdBbK3-AQ-yx3pI3Em6m-QoxVahVJD2HDabid2S7Mbd5FD_if_WBT_A0zAvz_swDCE3wGJgIO6PcX9wPk4Y8BiSmDF-RqbAChEB5GJCLr0_MsaKBbALMkmEyHgGYko-916bN-pH10iFtG-l76yhDr010oTE96gGZ72y_YkOlqqDdFIN6PQH0uGAVJuDrvSgQ8s2dLteRX3G59vd6x2Vpqa9s_8ybUI3CALvaXWivpNtSzvbohrbP5t1_oqcN7L1eP0zZ2S_etwtn6LNy_p5-bCJ-gRgiBRXOaRMNqgwSzBTFeNp2OuKL5pcIeRKylwIVYi84ZhVsigUa2pIEqGwwnRG5t_ecOn7iH4oO-0Vtq00aEdfQiaSdJFxAQG9_UHHqsO67J3upDuVv-9MvwDc8XlK</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Sheffield, Kristen S A</creator><creator>Vohra, Rahul</creator><creator>Scott, John A</creator><creator>Ross, Gregory M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</title><author>Sheffield, Kristen S A ; Vohra, Rahul ; Scott, John A ; Ross, Gregory M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-c5c8130afece72e7cb05330adb54f8ce18caa866c968f5e7ba99c0fd1226cebe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Heterocyclic Compounds, 3-Ring - pharmacology</topic><topic>Nerve Growth Factor - antagonists & inhibitors</topic><topic>Nerve Growth Factor - metabolism</topic><topic>Pteridines - pharmacology</topic><topic>Quinazolines - pharmacology</topic><topic>Receptor, Nerve Growth Factor - metabolism</topic><topic>Surface Plasmon Resonance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheffield, Kristen S A</creatorcontrib><creatorcontrib>Vohra, Rahul</creatorcontrib><creatorcontrib>Scott, John A</creatorcontrib><creatorcontrib>Ross, Gregory M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheffield, Kristen S A</au><au>Vohra, Rahul</au><au>Scott, John A</au><au>Ross, Gregory M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2016-01</date><risdate>2016</risdate><volume>103</volume><spage>292</spage><epage>299</epage><pages>292-299</pages><eissn>1096-1186</eissn><abstract>Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.</abstract><cop>Netherlands</cop><pmid>26675716</pmid><doi>10.1016/j.phrs.2015.12.005</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1096-1186 |
ispartof | Pharmacological research, 2016-01, Vol.103, p.292-299 |
issn | 1096-1186 |
language | eng |
recordid | cdi_proquest_miscellaneous_1762347561 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Heterocyclic Compounds, 3-Ring - pharmacology Nerve Growth Factor - antagonists & inhibitors Nerve Growth Factor - metabolism Pteridines - pharmacology Quinazolines - pharmacology Receptor, Nerve Growth Factor - metabolism Surface Plasmon Resonance |
title | Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A43%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20surface%20plasmon%20resonance%20spectroscopy%20to%20characterize%20the%20inhibition%20of%20NGF-p75(NTR)%20and%20proNGF-p75(NTR)%20interactions%20by%20small%20molecule%20inhibitors&rft.jtitle=Pharmacological%20research&rft.au=Sheffield,%20Kristen%20S%20A&rft.date=2016-01&rft.volume=103&rft.spage=292&rft.epage=299&rft.pages=292-299&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2015.12.005&rft_dat=%3Cproquest_pubme%3E1762347561%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1762347561&rft_id=info:pmid/26675716&rfr_iscdi=true |